Curetis has been developing and commercializing molecular diagnostic tests for more than 10 years.
The origin of the powerful Unyvero technology is in Germany, but our U.S. home is in San Diego, one of the nation’s premier biotech hubs.
Mission & Vision
It is Curetis’ mission to deliver fast syndromic diagnosis of serious infectious disease-causing microorganisms, helping clinicians provide early and effective treatment.
We envision a future where our technology can help save lives and reduce antibiotic resistance.
The Unyvero menu outside of the United States includes the following panels*: Pneumonia, Implant & Tissue Infections, Intra-Abdominal Infections, Urinary Tract Infections and Blood Culture, which are part of our growing pipeline of multiplex molecular panels designed to address critical infectious disease needs.